Spatial memory deficits in a virtual reality eight-arm radial maze in schizophrenia

Schizophrenia Research

Volumn 135, Issue 1-3, 2012, Pages 84-89

  Spieker, Elena A ^a   Astur, Robert S ^b   West, Jeffrey T ^a   Griego, Jacqueline A ^c   Rowland, Laura M ^a  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF OSNABRÜCK   (Germany)

Author keywords

Memory; Radial arm maze; Reference memory; Schizophrenia; Spatial learning; Working memory

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ANALYTICAL ERROR; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LEARNING; MALE; MAZE TEST; MEMORY DISORDER; MENTAL PERFORMANCE; MENTAL TASK; PRIORITY JOURNAL; RECALL; SCHIZOPHRENIA; SPATIAL MEMORY; SYMPTOM; VIRTUAL REALITY; WORKING MEMORY;

ACOUSTIC STIMULATION; ADULT; FEMALE; HUMANS; MALE; MAZE LEARNING; MEMORY DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SPACE PERCEPTION; TIME FACTORS; USER-COMPUTER INTERFACE;

EID: 84857233888     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2011.11.014     Document Type: Article

References (51)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Association, Washington, DC.
2. Andreasen N.C. The Scale for the Assessment of Negative Symptoms 1984, University of Iowa, Iowa City.
3. Astur R.S., St Germain S.A., Baker E., Calhoun V., Pearlson G.D., Constable R.T. fMRI hippocampal activity during a virtual radial arm maze. Appl. Psychophysiol. Biofeedback 2005, 30(3):307-317.
4. Astur R.S., Tropp J., Sava S., Constable R.T., Markus E.J. Sex differences and correlations in a virtual Morris water task, a virtual radial arm maze, and mental rotation. Behav. Brain Res. 2004, 151(1-2):103-115.
5. Baare W.F., van Oel C.J., Hulshoff Pol H.E., Schnack H.G., Durston S., Sitskoorn M.M., Kahn R.S. Volumes of brain structures in twins discordant for schizophrenia. Arch. Gen. Psychiatry 2001, 58(1):33-40.
6. Barch D.M., Berman M.G., Engle R., Jones J.H., Jonides J., Macdonald A., Nee D.E., Redick T.S., Sponheim S.R. CNTRICS final task selection: working memory. Schizophr. Bull. 2009, 35(1):136-152.
7. Carter C.S. Applying new approaches from cognitive neuroscience to enhance drug development for the treatment of impaired cognition in schizophrenia. Schizophr. Bull. 2005, 31(4):810-815.
8. Deicken R.F., Zhou L., Schuff N., Fein G., Weiner M.W. Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy. Biol. Psychiatry 1998, 43(7):483-488.
9. Dickinson D., Tenhula W., Morris S., Brown C., Peer J., Spencer K., Li L., Gold J.M., Bellack A.S. A randomized, controlled trial of computer-assisted cognitive remediation for schizophrenia. Am. J. Psychiatry 2010, 167(2):170-180.
10. Duncan G.E., Moy S.S., Knapp D.J., Mueller R.A., Breese G.R. Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia. Brain Res. 1998, 787(2):181-190.
11. Enomoto T., Floresco S.B. Disruptions in spatial working memory, but not short-term memory, induced by repeated ketamine exposure. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33(4):668-675.
12. First M.B., Spitzer R.L., Gibbon M., Williams J.B. Structured Clinical Interview for DSM-IV Axis I Disorders-Non-Patient Edition (SCID-I/NP), version 2.0. New York State Psychiatric Institute 1996, Biometrics Research, New York.
13. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-P), version 2. New York State Psychiatric Institute 1995, Biometrics Research, New York.
14. Fisher M., Holland C., Subramaniam K., Vinogradov S. Neuroplasticity-based cognitive training in schizophrenia: an interim report on the effects 6 months later. Schizophr. Bull. 2010, 36(4):869-879.
15. Floresco S.B., Geyer M.A., Gold L.H., Grace A.A. Developing predictive animal models and establishing a preclinical trials network for assessing treatment effects on cognition in schizophrenia. Schizophr. Bull. 2005, 31(4):888-894.
16. Floresco S.B., Seamans J.K., Phillips A.G. Selective roles for hippocampal, prefrontal cortical, and ventral striatal circuits in radial-arm maze tasks with or without a delay. J. Neurosci. 1997, 17(5):1880-1890.
17. Gao X.M., Shirakawa O., Du F., Tamminga C.A. Delayed regional metabolic actions of phencyclidine. Eur. J. Pharmacol. 1993, 241(1):7-15.
18. Genevsky A., Garrett C.T., Alexander P.P., Vinogradov S. Cognitive training in schizophrenia: a neuroscience-based approach. Dialogues Clin. Neurosci. 2010, 12(3):416-421.
19. Green M.F., Kern R.S., Braff D.L., Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?. Schizophr. Bull. 2000, 26(1):119-136.
20. Harvey P.D., Keefe R.S. Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment. Am. J. Psychiatry 2001, 158(2):176-184.
21. Hasselmo M.E. A model of prefrontal cortical mechanisms for goal-directed behavior. J. Cogn. Neurosci. 2005, 17(7):1115-1129.
22. He J., Xu H., Yang Y., Rajakumar D., Li X., Li X.M. The effects of chronic administration of quetiapine on the phencyclidine-induced reference memory impairment and decrease of Bcl-XL/Bax ratio in the posterior cingulate cortex in rats. Behav. Brain Res. 2006, 168(2):236-242.
23. Heinrichs R.W., Zakzanis K.K. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 1998, 12(3):426-445.
24. Iaria G., Petrides M., Dagher A., Pike B., Bohbot V.D. Cognitive strategies dependent on the hippocampus and caudate nucleus in human navigation: variability and change with practice. J. Neurosci. 2003, 23(13):5945-5952.
25. Jentsch J.D., Tran A., Le D., Youngren K.D., Roth R.H. Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat. Neuropsychopharmacology 1997, 17(2):92-99.
26. Jessen F., Scheef L., Germeshausen L., Tawo Y., Kockler M., Kuhn K.U., Maier W., Schild H.H., Heun R. Reduced hippocampal activation during encoding and recognition of words in schizophrenia patients. Am. J. Psychiatry 2003, 160(7):1305-1312.
27. Keefe R.S., Bilder R.M., Davis S.M., Harvey P.D., Palmer B.W., Gold J.M., Meltzer H.Y., Green M.F., Capuano G., Stroup T.S., McEvoy J.P., Swartz M.S., Rosenheck R.A., Perkins D.O., Davis C.E., Hsiao J.K., Lieberman J.A. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch. Gen. Psychiatry 2007, 64(6):633-647.
28. Kenchaiah S., Evans J.C., Levy D., Wilson P.W.F., Benjamin E.J., Larson M.G., Kannel W.B., Vasan R.S. Obesity and the risk of heart failure. N. Engl. J. Med. 2002, 347:305-313.
29. Liu P., Bilkey D.K. The effect of excitotoxic lesions centered on the perirhinal cortex in two versions of the radial arm maze task. Behav. Neurosci. 1999, 113(4):672-682.
30. Marsh R., Hao X., Xu D., Wang Z., Duan Y., Liu J., Kangarlu A., Martinez D., Garcia F., Tau G.Z., Yu S., Packard M.G., Peterson B.S. A virtual reality-based FMRI study of reward-based spatial learning. Neuropsychologia 2010, 48(10):2912-2921.
31. Martin S.J., Clark R.E. The rodent hippocampus and spatial memory: from synapses to systems. Cell. Mol. Life Sci. 2007, 64(4):401-431.
32. McGurk S.R., Twamley E.W., Sitzer D.I., McHugo G.J., Mueser K.T. A meta-analysis of cognitive remediation in schizophrenia. Am. J. Psychiatry 2007, 164(12):1791-1802.
33. Mintz J., Kopelowicz A. CUtLASS confirms CATIE. Arch. Gen. Psychiatry 2007, 64(8):979-980. 978; author reply.
34. Mouri A., Noda Y., Noda A., Nakamura T., Tokura T., Yura Y., Nitta A., Furukawa H., Nabeshima T. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine. Mol. Pharmacol. 2007, 71(6):1598-1609.
35. Muzzio I.A., Kentros C., Kandel E. What is remembered?, Role of attention on the encoding and retrieval of hippocampal representations. J. Physiol. 2009, 587(Pt 12):2837-2854.
36. Myhrer T. Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks. Brain Res. Brain Res. Rev. 2003, 41(2-3):268-287.
37. Noda Y., Kamei H., Mamiya T., Furukawa H., Nabeshima T. Repeated phencyclidine treatment induces negative symptom-like behavior in forced swimming test in mice: imbalance of prefrontal serotonergic and dopaminergic functions. Neuropsychopharmacology 2000, 23(4):375-387.
38. Olton D.S., Samuelson R.J. Remembrance of places passed: spatial memory in rats. J. Exp. Psychol. Anim. Behav. Process. 1976, 2:97-I16.
39. Otto T., Wolf D., Walsh T.J. Combined lesions of perirhinal and entorhinal cortex impair rats' performance in two versions of the spatially guided radial-arm maze. Neurobiol. Learn. Mem. 1997, 68(1):21-31.
40. Overall J., Gorham D. The brief psychiatric rating scale. Psychol. Rep. 1962, 10:799-812.
41. Packard M.G., McGaugh J.L. Inactivation of hippocampus or caudate nucleus with lidocaine differentially affects expression of place and response learning. Neurobiol. Learn. Mem. 1996, 65(1):65-72.
42. Park S., Holzman P.S. Schizophrenics show spatial working memory deficits. Arch. Gen. Psychiatry 1992, 49(12):975-982.
43. Piskulic D., Olver J.S., Norman T.R., Maruff P. Behavioural studies of spatial working memory dysfunction in schizophrenia: a quantitative literature review. Psychiatry Res. 2007, 150(2):111-121.
44. Reichenberg A., Harvey P.D. Neuropsychological impairments in schizophrenia: integration of performance-based and brain imaging findings. Psychol. Bull. 2007, 133(5):833-858.
45. Rowland L.M. Subanesthetic ketamine: how it alters physiology and behavior in humans. Aviat. Space Environ. Med. 2005, 76(7 Suppl):C52-C58.
46. Rowland L.M., Astur R.S., Jung R.E., Bustillo J.R., Lauriello J., Yeo R.A. Selective cognitive impairments associated with NMDA receptor blockade in humans. Neuropsychopharmacology 2005, 30(3):633-639.
47. Rowland L.M., Griego J.A., Spieker E.A., Cortes C.R., Holcomb H.H. Neural changes associated with relational learning in schizophrenia. Schizophr. Bull. 2010, 36(3):496-503.
48. Sharma T., Antonova L. Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment. Psychiatr. Clin. North Am. 2003, 26(1):25-40.
49. Tsien J.Z., Heurta P.T., Tonegawa S. The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell Calcium 1996, 87:1327-1338.
50. Walker J.A., Olton D.S. Spatial memory deficit following fimbria-fornix lesions: independent of time for stimulus processing. Physiol. Behav. 1979, 23(1):11-15.
51. Wykes T., Huddy V., Cellard C., McGurk S.R., Czobor P. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am. J. Psychiatry 2011, 168(5):472-485.